Concepedia

Annemie A. Van Linden

AA

Statistics

Publications

6

Citations

260

H-Index

6

Active since

2000

Affiliations

University of Colorado Denver(Current)

University of Colorado Health

National Jewish Health

Annemie A. Van Linden is an author at University of Colorado Denver specializing in cell biology, cell death, and cellular biochemistry.

Top concepts

Publications per year

2000–2020

6

Publications

6

Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics <i>In Vitro</i> and <i>In Vivo</i> , Independent of p53 Functionality

Annemie A. Van Linden, Dmitry Baturin, James B. Ford et al. · Molecular Cancer Therapeutics · 2013 · 128 citations · Full text

AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair

James B. Ford, Dmitry Baturin, Tamara M. Burleson et al. · Oncotarget · 2015 · 44 citations · Full text

Phosphorylation of the Membrane Proximal Region of Tumor Necrosis Factor Receptor CD120a (p55) at ERK Consensus Sites

Annemie A. Van Linden, Vincent Cottin, Cheryl Y. Leu et al. · Journal of Biological Chemistry · 2000 · 28 citations · Full text

Phosphorylation of the Tumor Necrosis Factor Receptor CD120a (p55) Recruits Bcl-2 and Protects against Apoptosis

Vincent Cottin, Annemie A. Van Linden, David W. H. Riches · Journal of Biological Chemistry · 2001 · 26 citations · Full text

Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia

Tamara B. Garcia, Rizvan C Uluisik, Annemie A. Van Linden et al. · Frontiers in Oncology · 2020 · 18 citations · Full text

1–5 of 6